Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.

Hammarström H, Grankvist A, Broman I, Kondori N, Wennerås C, Gisslen M, Friman V.

BMC Infect Dis. 2019 Jul 23;19(1):658. doi: 10.1186/s12879-019-4289-4.

2.

Polyunsaturated fatty acids in cod evoke chemotaxis and mobilize intracellular calcium in human eosinophils in part via FFAR4.

Lingblom C, Redvall E, Andersson K, Wennerås C.

Allergy. 2019 Jun 24. doi: 10.1111/all.13955. [Epub ahead of print] No abstract available.

PMID:
31233612
3.

High frequency of concomitant food allergy development and autoantibody formation in children who have undergone liver transplantation.

Käppi T, Rabe H, Lingblom C, Hesselmar B, Kullberg-Lindh C, Wold AE, Wennerås C, Saalman R.

Transplantation. 2019 Apr 8. doi: 10.1097/TP.0000000000002751. [Epub ahead of print]

PMID:
30985574
4.

Cultivation of the causative agent of human neoehrlichiosis from clinical isolates identifies vascular endothelium as a target of infection.

Wass L, Grankvist A, Bell-Sakyi L, Bergström M, Ulfhammer E, Lingblom C, Wennerås C.

Emerg Microbes Infect. 2019;8(1):413-425. doi: 10.1080/22221751.2019.1584017.

5.

Serological reactivity to Anaplasma phagocytophilum in neoehrlichiosis patients.

Wass L, Grankvist A, Mattsson M, Gustafsson H, Krogfelt K, Olsen B, Nilsson K, Mårtensson A, Quarsten H, Henningsson AJ, Wennerås C.

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1673-1678. doi: 10.1007/s10096-018-3298-3. Epub 2018 Jun 14.

6.

Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.

Hammarström H, Stjärne Aspelund A, Christensson B, Heußel CP, Isaksson J, Kondori N, Larsson L, Markowicz P, Richter J, Wennerås C, Friman V.

Mycoses. 2018 Sep;61(9):623-632. doi: 10.1111/myc.12773. Epub 2018 Jun 26.

PMID:
29577474
7.

A man in his sixties from Southern Norway with intermittent fever.

Frivik JO, Noraas S, Grankvist A, Wennerås C, Quarsten H.

Tidsskr Nor Laegeforen. 2017 Dec 12;137(23-24). doi: 10.4045/tidsskr.17.0353. Print 2017 Dec 12. English, Norwegian. No abstract available.

8.

[Fever of unknown origin in a multiple sclerosis patient on immunomodulatory therapy was due to neoehrlichiosis].

Dadgar A, Grankvist A, Wernbro L, Wennerås C.

Lakartidningen. 2017 Sep 18;114. pii: EM6L. Swedish.

9.

Natural IgM antibodies in the immune defence against neoehrlichiosis.

Wennerås C, Goldblatt D, Zancolli M, Mattsson M, Wass L, Hörkkö S, Rosén A.

Infect Dis (Lond). 2017 Nov - Dec;49(11-12):809-816. doi: 10.1080/23744235.2017.1347815. Epub 2017 Jul 6.

PMID:
28682152
10.

Candidatus Neoehrlichia mikurensis and Borrelia burgdorferi sensu lato detected in the blood of Norwegian patients with erythema migrans.

Quarsten H, Grankvist A, Høyvoll L, Myre IB, Skarpaas T, Kjelland V, Wenneras C, Noraas S.

Ticks Tick Borne Dis. 2017 Aug;8(5):715-720. doi: 10.1016/j.ttbdis.2017.05.004. Epub 2017 May 13.

PMID:
28539197
11.

Regulatory Eosinophils Suppress T Cells Partly through Galectin-10.

Lingblom C, Andersson J, Andersson K, Wennerås C.

J Immunol. 2017 Jun 15;198(12):4672-4681. doi: 10.4049/jimmunol.1601005. Epub 2017 May 17.

12.

Differences in eosinophil molecular profiles between children and adults with eosinophilic esophagitis.

Lingblom C, Käppi T, Bergquist H, Bove M, Arkel R, Saalman R, Wennerås C.

Allergy. 2017 Sep;72(9):1406-1414. doi: 10.1111/all.13140. Epub 2017 Mar 17.

PMID:
28194801
13.

Eosinophils from eosinophilic oesophagitis patients have T cell suppressive capacity and express FOXP3.

Lingblom C, Wallander J, Ingelsten M, Bergquist H, Bove M, Saalman R, Welin A, Wennerås C.

Clin Exp Immunol. 2017 Mar;187(3):455-465. doi: 10.1111/cei.12898. Epub 2016 Dec 6.

14.

Graft-versus-host Disease After Intestinal or Multivisceral Transplantation: A Scandinavian Single-center Experience.

Cromvik J, Varkey J, Herlenius G, Johansson JE, Wennerås C.

Transplant Proc. 2016 Jan-Feb;48(1):185-90. doi: 10.1016/j.transproceed.2015.11.007.

PMID:
26915866
15.

Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia.

Karlsson J, Roalfe L, Hogevik H, Zancolli M, Andréasson B, Goldblatt D, Wennerås C.

Clin Vaccine Immunol. 2016 Apr 4;23(4):379-85. doi: 10.1128/CVI.00654-15. Print 2016 Apr.

16.

Infections with Candidatus Neoehrlichia mikurensis and Cytokine Responses in 2 Persons Bitten by Ticks, Sweden.

Grankvist A, Sandelin LL, Andersson J, Fryland L, Wilhelmsson P, Lindgren PE, Forsberg P, Wennerås C.

Emerg Infect Dis. 2015 Aug;21(8):1462-5. doi: 10.3201/eid2108.150060.

17.

Multilocus Sequence Analysis of Clinical "Candidatus Neoehrlichia mikurensis" Strains from Europe.

Grankvist A, Moore ER, Svensson Stadler L, Pekova S, Bogdan C, Geißdörfer W, Grip-Lindén J, Brandström K, Marsal J, Andréasson K, Lewerin C, Welinder-Olsson C, Wennerås C.

J Clin Microbiol. 2015 Oct;53(10):3126-32. doi: 10.1128/JCM.00880-15. Epub 2015 Jul 8.

18.

Infections with the tick-borne bacterium Candidatus Neoehrlichia mikurensis.

Wennerås C.

Clin Microbiol Infect. 2015 Jul;21(7):621-30. doi: 10.1016/j.cmi.2015.02.030. Epub 2015 Mar 11. Review.

19.

Exploring a cascade Heck-Suzuki reaction based route to kinase inhibitors using design of experiments.

Ekebergh A, Lingblom C, Sandin P, Wennerås C, Mårtensson J.

Org Biomol Chem. 2015 Mar 21;13(11):3382-92. doi: 10.1039/c4ob02694b.

PMID:
25658776
20.

How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.

Hammarström H, Kondori N, Friman V, Wennerås C.

Eur J Clin Microbiol Infect Dis. 2015 May;34(5):917-25. doi: 10.1007/s10096-014-2302-9. Epub 2015 Jan 9.

PMID:
25573536
21.

Recurrent fever caused by Candidatus Neoehrlichia mikurensis in a rheumatoid arthritis patient treated with rituximab.

Andréasson K, Jönsson G, Lindell P, Gülfe A, Ingvarsson R, Lindqvist E, Saxne T, Grankvist A, Wennerås C, Marsal J.

Rheumatology (Oxford). 2015 Feb;54(2):369-71. doi: 10.1093/rheumatology/keu441. Epub 2014 Nov 20. No abstract available.

PMID:
25416710
22.

Eosinophils in the blood of hematopoietic stem cell transplanted patients are activated and have different molecular marker profiles in acute and chronic graft-versus-host disease.

Cromvik J, Johnsson M, Vaht K, Johansson JE, Wennerås C.

Immun Inflamm Dis. 2014 Aug;2(2):99-113. doi: 10.1002/iid3.25. Epub 2014 Jul 7.

23.

Eosinophils from hematopoietic stem cell recipients suppress allogeneic T cell proliferation.

Andersson J, Cromvik J, Ingelsten M, Lingblom C, Andersson K, Johansson JE, Wennerås C.

Biol Blood Marrow Transplant. 2014 Dec;20(12):1891-8. doi: 10.1016/j.bbmt.2014.08.017. Epub 2014 Aug 28.

24.

Reply to Raoult.

Wennerås C, Bloemberg G, Bogdan C.

Clin Infect Dis. 2014 Oct;59(7):1042-3. doi: 10.1093/cid/ciu494. Epub 2014 Jun 25. No abstract available.

PMID:
24965349
25.

Topical corticosteroids do not revert the activated phenotype of eosinophils in eosinophilic esophagitis but decrease surface levels of CD18 resulting in diminished adherence to ICAM-1, ICAM-2, and endothelial cells.

Lingblom C, Bergquist H, Johnsson M, Sundström P, Quiding-Järbrink M, Bove M, Wennerås C.

Inflammation. 2014 Dec;37(6):1932-44. doi: 10.1007/s10753-014-9926-x.

PMID:
24870064
26.

Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases.

Grankvist A, Andersson PO, Mattsson M, Sender M, Vaht K, Höper L, Sakiniene E, Trysberg E, Stenson M, Fehr J, Pekova S, Bogdan C, Bloemberg G, Wennerås C.

Clin Infect Dis. 2014 Jun;58(12):1716-22. doi: 10.1093/cid/ciu189. Epub 2014 Mar 18.

27.

Distinct inflammatory mediator patterns characterize infectious and sterile systemic inflammation in febrile neutropenic hematology patients.

Wennerås C, Hagberg L, Andersson R, Hynsjö L, Lindahl A, Okroj M, Blom AM, Johansson P, Andreasson B, Gottfries J, Wold AE.

PLoS One. 2014 Mar 18;9(3):e92319. doi: 10.1371/journal.pone.0092319. eCollection 2014.

28.

Development of IgG antibodies to Exophiala dermatitidis is associated with inflammatory responses in patients with cystic fibrosis.

Kondori N, Lindblad A, Welinder-Olsson C, Wennerås C, Gilljam M.

J Cyst Fibros. 2014 Jul;13(4):391-9. doi: 10.1016/j.jcf.2013.12.007. Epub 2014 Jan 14.

29.

Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy.

Johnsson M, Bove M, Bergquist H, Olsson M, Fornwall S, Hassel K, Wold AE, Wennerås C.

J Innate Immun. 2011;3(6):594-604. doi: 10.1159/000331326. Epub 2011 Sep 13.

30.

Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance.

Karlsson J, Andréasson B, Kondori N, Erman E, Riesbeck K, Hogevik H, Wennerås C.

Clin Vaccine Immunol. 2011 Jun;18(6):969-77. doi: 10.1128/CVI.00021-11. Epub 2011 Apr 20.

31.

High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency.

Kondori N, Gilljam M, Lindblad A, Jönsson B, Moore ER, Wennerås C.

J Clin Microbiol. 2011 Mar;49(3):1004-9. doi: 10.1128/JCM.01899-10. Epub 2011 Jan 5.

32.

Comparison of a new commercial test, Dermatophyte-PCR kit, with conventional methods for rapid detection and identification of Trichophyton rubrum in nail specimens.

Kondori N, Abrahamsson AL, Ataollahy N, Wennerås C.

Med Mycol. 2010 Nov;48(7):1005-8. doi: 10.3109/13693781003743130.

PMID:
20370367
33.

First case of human "Candidatus Neoehrlichia mikurensis" infection in a febrile patient with chronic lymphocytic leukemia.

Welinder-Olsson C, Kjellin E, Vaht K, Jacobsson S, Wennerås C.

J Clin Microbiol. 2010 May;48(5):1956-9. doi: 10.1128/JCM.02423-09. Epub 2010 Mar 10.

34.

Optimization of the detection of microbes in blood from immunocompromised patients with haematological malignancies.

Skovbjerg S, Welinder-Olsson C, Kondori N, Kjellin E, Nowrouzian F, Wold AE, Stockelberg D, Larsson P, Wennerås C.

Clin Microbiol Infect. 2009 Jul;15(7):680-3. doi: 10.1111/j.1469-0691.2009.02796.x. Epub 2009 Jul 14.

35.

Interplay between signaling via the formyl peptide receptor (FPR) and chemokine receptor 3 (CCR3) in human eosinophils.

Svensson L, Redvall E, Johnsson M, Stenfeldt AL, Dahlgren C, Wennerås C.

J Leukoc Biol. 2009 Aug;86(2):327-36. doi: 10.1189/jlb.0908514. Epub 2009 May 4.

PMID:
19414538
36.

CC16 inhibits the migration of eosinophils towards the formyl peptide fMLF but not towards PGD2.

Johansson S, Andersson K, Wennergren G, Wennerås C, Rudin A.

Inflammation. 2009 Apr;32(2):65-9. doi: 10.1007/s10753-008-9103-1.

PMID:
19132521
37.

Responsiveness of eosinophils to aeroallergens may be independent of atopic status.

Redvall E, Bengtsson U, Wennerås C.

Scand J Immunol. 2008 Apr;67(4):377-84. doi: 10.1111/j.1365-3083.2008.02081.x. Epub 2008 Feb 12.

38.

The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.

Stenfeldt AL, Karlsson J, Wennerås C, Bylund J, Fu H, Dahlgren C.

Biochem Pharmacol. 2007 Oct 1;74(7):1050-6. Epub 2007 Jul 7.

PMID:
17692291
39.

Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor.

Stenfeldt AL, Karlsson J, Wennerås C, Bylund J, Fu H, Dahlgren C.

Inflammation. 2007 Dec;30(6):224-9. Epub 2007 Aug 9.

PMID:
17687636
40.

House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1.

Svensson L, Redvall E, Björn C, Karlsson J, Bergin AM, Rabiet MJ, Dahlgren C, Wennerås C.

Eur J Immunol. 2007 Jul;37(7):1966-77.

41.

Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups.

Svensson L, Wennerås C.

Microbes Infect. 2005 Apr;7(4):720-8. Epub 2005 Mar 22.

PMID:
15857806
42.
43.
44.

Allergen extracts directly mobilize and activate human eosinophils.

Svensson L, Rudin A, Wennerås C.

Eur J Immunol. 2004 Jun;34(6):1744-51.

45.

Neuromodulation of experimental Shigella infection reduces damage to the gut mucosa.

Svensson L, Bergquist J, Wennerås C.

Microbes Infect. 2004 Mar;6(3):256-64.

PMID:
15026012
47.

Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139.

Qadri F, Raqib R, Ahmed F, Rahman T, Wenneras C, Das SK, Alam NH, Mathan MM, Svennerholm AM.

Clin Diagn Lab Immunol. 2002 Mar;9(2):221-9.

48.

Blockade of CD14 aggravates experimental shigellosis.

Wennerås C, Ave P, Huerre M, Arondel J, Ulevitch R, Mathison J, Sansonetti P.

J Endotoxin Res. 2001;7(6):442-6.

PMID:
11753214
49.

A chair of one's own.

Wennerås C, Wold A.

Nature. 2000 Dec 7;408(6813):647. No abstract available.

PMID:
11130048
50.

Enterotoxin-specific immunoglobulin E responses in humans after infection or vaccination with diarrhea-causing enteropathogens.

Qadri F, Asaduzzaman M, Wennerås C, Mohi G, Albert MJ, Abdus Salam M, Sack RB, Jertborn M, McGhee JR, Sack DA, Holmgren J.

Infect Immun. 2000 Oct;68(10):6077-81.

Supplemental Content

Loading ...
Support Center